urea has been researched along with 1-cyclohexyl-3-dodecylurea in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hammock, BD; Watanabe, T | 1 |
| Davis, BB; Hammock, BD; Howard, LL; Morisseau, C; Thompson, DA; Weiss, RH | 1 |
| Hammock, BD; Morisseau, C; Newman, JW; Watanabe, T | 1 |
| Hammock, BD; Imig, JD; Kim, IH; Newman, JW; Pollock, DM; Pollock, JS; Stewart, J; Watanabe, T; Yamamoto, T; Zhao, X | 1 |
| Davis, BB; Hammock, BD; Morisseau, C; Newman, JW; Pedersen, TL; Weiss, RH | 1 |
| Benter, IF; Roman, RJ; Yousif, MH | 1 |
| Benter, IF; Yousif, MH | 1 |
7 other study(ies) available for urea and 1-cyclohexyl-3-dodecylurea
| Article | Year |
|---|---|
Rapid determination of soluble epoxide hydrolase inhibitors in rat hepatic microsomes by high-performance liquid chromatography with electrospray tandem mass spectrometry.
Topics: Adamantane; Animals; Chromatography, High Pressure Liquid; Enzyme Inhibitors; Epoxide Hydrolases; Male; Microsomes, Liver; Rats; Rats, Inbred F344; Spectrometry, Mass, Electrospray Ionization; Urea | 2001 |
Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation.
Topics: Blotting, Western; Cell Division; Cell Line; Cell Nucleus; Cells, Cultured; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epoxide Hydrolases; G1 Phase; Humans; MAP Kinase Signaling System; Muscle, Smooth; Muscle, Smooth, Vascular; Recombinant Proteins; S Phase; Thymidine; Time Factors; Urea | 2002 |
In vitro metabolism of the mammalian soluble epoxide hydrolase inhibitor, 1-cyclohexyl-3-dodecyl-urea.
Topics: Animals; Biotransformation; Chromatography, High Pressure Liquid; Clofibrate; Cyclohexanes; Cytochrome P-450 Enzyme System; Epoxide Hydrolases; Humans; Lauric Acids; Male; Mass Spectrometry; Microsomes, Liver; NAD; NADPH Dehydrogenase; Rats; Rats, Inbred F344; Solubility; Species Specificity; Time Factors; Urea | 2003 |
Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage.
Topics: Angiotensin II; Animals; Arachidonic Acid; Arterioles; Blood Pressure; Epoxide Hydrolases; Heart Rate; Hypertension, Renal; Kidney; Linoleic Acid; Male; Rats; Rats, Sprague-Dawley; Solubility; Urea; Vasoconstrictor Agents | 2004 |
Attenuation of vascular smooth muscle cell proliferation by 1-cyclohexyl-3-dodecyl urea is independent of soluble epoxide hydrolase inhibition.
Topics: Aorta; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Eicosanoic Acids; Epoxide Hydrolases; Humans; Molecular Structure; Muscle, Smooth, Vascular; Solubility; Structure-Activity Relationship; Urea | 2006 |
Cytochrome P450 metabolites of arachidonic acid play a role in the enhanced cardiac dysfunction in diabetic rats following ischaemic reperfusion injury.
Topics: 8,11,14-Eicosatrienoic Acid; Amidines; Animals; Arachidonic Acid; Blood Glucose; Body Weight; Coronary Circulation; Cytochrome P-450 Enzyme System; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Epoxide Hydrolases; Glyburide; Heart; Hydroxyeicosatetraenoic Acids; Male; Microsomes; Myocardium; Rats; Rats, Wistar; Reperfusion Injury; Urea; Vascular Resistance; Ventricular Dysfunction, Left | 2009 |
Role of 20-hydroxyeicosatetraenoic and epoxyeicosatrienoic acids in the regulation of vascular function in a model of hypertension and endothelial dysfunction.
Topics: Amidines; Animals; Arachidonic Acids; Blood Pressure; Carbachol; Cardiovascular Physiological Phenomena; Carotid Arteries; Endothelial Cells; Hydroxyeicosatetraenoic Acids; Hypertension; Male; Norepinephrine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Urea; Vascular Diseases; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 2010 |